Drug Approval | April 18, 2022
Amneal achieves second U.S. biosimilars approval with Alymsys
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors
Fujifilm’s NEVER STOP philosophy to enhance the access to healthcare for all Indians
This product will be manufactured at Lupin’s Nagpur facility in India
The initial courses of Lap. Hernia Masterclass will encompass commonly performed hernia procedures
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research
The ultrasound products manufactured in the new manufacturing facility will be sold under the brand name SonoRad, and are designed for large hospitals, healthcare institutions and individual radiology centres
First of its kind interactive concept store ‘Brilliant Sound Galaxy (BSG)’ in the capital city
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
Subscribe To Our Newsletter & Stay Updated
